Cited 0 times in
Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 라선영 | - |
dc.date.accessioned | 2023-06-02T00:51:43Z | - |
dc.date.available | 2023-06-02T00:51:43Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194478 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sun Young Rha | - |
dc.contributor.googleauthor | Toni K. Choueiri | - |
dc.contributor.googleauthor | Vsevolod B. Matveev | - |
dc.contributor.googleauthor | Anna Alyasova | - |
dc.contributor.googleauthor | Sung-Hoo Hong | - |
dc.contributor.googleauthor | Teresa Alonso Gordoa | - |
dc.contributor.googleauthor | Howard Gurney | - |
dc.contributor.googleauthor | Georg A. Bjarnason | - |
dc.contributor.googleauthor | Tomas Buchler | - |
dc.contributor.googleauthor | Paolo Pedrazzoli | - |
dc.contributor.googleauthor | Toshio Takagi | - |
dc.contributor.googleauthor | Se Hoon Park | - |
dc.contributor.googleauthor | Jae-Lyun Lee | - |
dc.contributor.googleauthor | Rodolfo F. Perini | - |
dc.contributor.googleauthor | Cixin He | - |
dc.contributor.googleauthor | Jodi A. McKenzie | - |
dc.contributor.googleauthor | Masatoshi Eto | - |
dc.identifier.doi | 10.1200/JCO.2022.40.6_suppl.338 | - |
dc.contributor.localId | A01316 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.338 | - |
dc.contributor.alternativeName | Rha, Sun Young | - |
dc.contributor.affiliatedAuthor | 라선영 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 6 Suppl | - |
dc.citation.startPage | S338 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(6 Suppl) : S338, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.